Sprint Bioscience AB (publ) (STO:SPRINT)
Sweden · Delayed Price · Currency is SEK 3.630
-0.120 (-3.20%)
Jul 24, 2026, 4:17 PM CET
Sprint Bioscience AB Market Cap
Sprint Bioscience AB has a market cap or net worth of 395.68 million as of July 24, 2026. Its market cap has increased by 626.74% in one year.
Market Cap
395.68M
Enterprise Value
287.35M
Revenue
153.28M
Ranking
n/a
PE Ratio
4.55
Stock Price
3.63
ChartMarket Cap Chart
Since November 7, 2014, Sprint Bioscience AB's market cap has increased from 62.49M to 395.68M, an increase of 533.15%. That is a compound annual growth rate of 17.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2026 | 377.75M | 143.54% |
| Dec 30, 2025 | 155.11M | 40.43% |
| Dec 30, 2024 | 110.46M | -8.82% |
| Dec 29, 2023 | 121.14M | 449.78% |
| Dec 30, 2022 | 22.03M | -88.47% |
| Dec 30, 2021 | 191.05M | 17.26% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xspray Pharma AB | 711.25M |
| Oncopeptides AB | 617.04M |
| FluoGuide | 534.62M |
| Corline Biomedical AB | 467.78M |
| Cantargia AB | 456.95M |
| Intervacc AB | 396.02M |
| Mendus AB | 385.88M |
| Isofol Medical AB | 237.48M |